Log In
BCIQ
Print this Print this
 

zafirlukast (INV104)

  Manage Alerts
Collapse Summary General Information
Company Accolade Pharmaceuticals LLC
DescriptionInhaled formulation of zafirlukast
Molecular Target
Mechanism of ActionNSAID; Leukotriene receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation
PartnerInvion Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$0.5M

$0.5M

0


 Deals Details
Get a free BioCentury trial today